The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance?

Giovam Battista Rini, Manfredi Rizzo, Kaspar Berneis, Emanuel R. Christ, Giatgen A. Spinas

Risultato della ricerca: Article

17 Citazioni (Scopus)
Lingua originaleEnglish
pagine (da-a)2295-2303
Numero di pagine9
RivistaExpert Opinion on Pharmacotherapy
Volume9
Stato di pubblicazionePublished - 2008

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Cita questo

@article{9fead6efdadd4aca9f3416aa83330b67,
title = "The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance?",
keywords = "Thiazolidindiones,Atherogenic dyslipidemia",
author = "Rini, {Giovam Battista} and Manfredi Rizzo and Kaspar Berneis and Christ, {Emanuel R.} and Spinas, {Giatgen A.}",
year = "2008",
language = "English",
volume = "9",
pages = "2295--2303",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance?

AU - Rini, Giovam Battista

AU - Rizzo, Manfredi

AU - Berneis, Kaspar

AU - Christ, Emanuel R.

AU - Spinas, Giatgen A.

PY - 2008

Y1 - 2008

KW - Thiazolidindiones,Atherogenic dyslipidemia

UR - http://hdl.handle.net/10447/77622

M3 - Article

VL - 9

SP - 2295

EP - 2303

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

ER -